|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
, S% J6 R: u K R) Ewas to close its brain research facility in Basel, Switzerland,/ M. L6 c6 M8 }
the story noted that this move closely followed similar cuts6 t1 Q2 u/ H. c9 b
by rival pharmaceutical firms. As a report from the European College: D+ {% t. `4 t' e( d
of Neuropsychopharmacology5 _" g8 X! a* B9 O
had warned a few months earlier, the
7 ^5 X! |4 N3 q0 I! {$ Q* w* sabandonment of research into new psychiatric drugs by AstraZeneca,
% b) g. S7 H' lGlaxoSmithKline
; g q2 {+ u. @! }0 g' Y2 M$ o, Wand others meant that “withdrawal of research/ L8 V$ `" M/ ?* A6 Q3 W0 R1 ]* n! P
resources is a withdrawal of hope for patients and their families”.
8 h1 B! T# q( w$ n) v
9 r( R7 v% X; @, C# n$ l5 U# H. s) |, s( g7 @4 x
回复有免费下载链接
/ }- w/ v* y' r9 \2 ?- J
2 q% s+ y6 M7 Y% c3 [- Q$ r9 H |
-
总评分: 包包 + 20
查看全部评分
|